´
´
5
M. Cwiklinska et al. / Tetrahedron: Asymmetry xxx (2015) xxx–xxx
uncorrected. Elemental analyses were performed on Vario MACRO
CHN, ELEMENTAR Analysensysteme GmbH instrument.
41.10, 45.00, 45.06, 52.41, 76.02, 76.71, 82.40; 11B NMR (CDCl3):
d = 12.90 (79%), 22.37 (21%); Anal. calcd for C19H32BNO3: C,
68.47, H, 9.68, N, 4.20; found: C, 68.55, H, 9.42, N, 4.08.
4.2. Materials
4.3.3. (1R,2S,3R,5R)-2-(10,30,20-Dioxaborolan-(40-3,50-4-(1S,3S,4R,
6R)-caran)-20-yloxy)-apopinan-3-amine 3
Silica Gel 60, Merck 230–400 mesh, was used for preparative col-
umn flash chromatography. Analytical TLC was performed using
Merck TLCSilicagel 60F254 0.2 mmaluminum plates. THF was freshly
distilled from sodium benzophenone ketyl. Chloroform, methanol,
and toluene were dried over 4 Å molecular sieves. (S)-Prolinol, 2-ami-
noethanol, ethylene glycol, 1,4-anhydroerythritol, cis-1,2-cyclopen-
tanediol, triisopropyl borate, borane–dimethyl sulfide adduct,
borane tetrahydrofuran complex, BACH-EITM, catecholborane, ace-
tophenone, and substituted acetophenones, 1-(naphthalen-1-yl)
ethanone, octan-2-one, 2-bromo-1-phenylethanone, 2-chloro-1-
phenylethanone, 2-chloro-1-(4-chlorophenyl)ethanone, and 3-
chloro-1-phenylpropan-1-one were commercial products (Aldrich).
(1R,2S,3R,5R)-3-Amino-apopinan-2-ol,21,22 (1S,3S,4R,6R)-4-amino-
caran-3-ol,23,24 (1S,2S,3S,4S,5R)-4-amino-2-methoxy-pinan-3-ol,25
White solid; mp 149–152 °C; [
a
]
D
20 = ꢀ17.5 (c 0.6, THF); 1H NMR
(CDCl3): d = 0.54–0.77 (m, 3H), 0.79–0.88 (m, 1H), 0.97 (s, 3H), 1.03
(d, J = 10.4 Hz, 1H), 1.07 (s, 3H), 1.08 (s, 3H), 1.22 (s, 3H), 1.25 (s,
3H), 1.71 (dd, J = 13.9, 6.4 Hz, 1H), 1.87–2.03 (m, 2H), 2.10 (ddd,
J = 15.3, 7.2, 1.7 Hz, 1H), 2.19–2.28 (m, 1H), 2.38–2.44 (m, 1H),
2.47–2.59 (m, 1H), 3.26 (br s, 2H), 3.69 (q, J = 8.1 Hz, 1H), 4.00 (s,
1H), 4.53 (dd, J = 8.3, 4.5 Hz, 1H); 13C NMR (CDCl3): d = 14.60,
16.44, 18.21, 18.98, 22.58, 25.28, 25.99, 27.42, 28.64, 29.75,
31.00, 34.89, 38.04, 41.05, 45.03, 45.09, 76.16, 77.46, 79.38; 11B
NMR (CDCl3): d = 12.86 (65%), 22.07 (35%); Anal. calcd for C19H32
-
BNO3: C, 68.47, H, 9.68, N, 4.20; found: C, 68.73, H, 9.04, N, 4.33.
4.3.4. (1R,2S,3R,5R)-2-(10,30,20-Dioxaborolan-(40-3,50-4-tetrahyd-
(1S,2S,3R,5S)-pinane-2,3-diol,26
(1S,3S,4R,6R)-carane-3,4-diol,27
(1R,2R,3S,5R)-pinane-2,3-diol,26
rofuran)-20-yloxy)-apopinan-3-amine 4
1-(benzofuran-2-yl)ethanone,33
White solid; mp 223–228 °C; [
a
]
D
20 = ꢀ28.5 (c 0.6, THF); 1H NMR
benzofuran-2-yl(phenyl)methanone,34 benzofuran-2-yl(4-methoxy-
phenyl)methanone,35 1-(benzofuran-2-yl)-2-bromoethanone,36 and
2-bromo-1-(7-ethylbenzofuran-2-yl)ethanone31 were prepared
according to the literature.
(CDCl3): d = 1.01 (d, J = 10.6 Hz, 1H), 1.06 (s, 3H), 1.24 (s, 3H), 1.73
(ddt, J = 13.8, 5.8, 1.4 Hz, 1H), 1.99 (q, J = 5.0 Hz, 1H), 2.26–2.32 (m,
1H), 2.36–2.40 (m, 1H), 2.61 (ddd, J = 14.1, 9.6, 4.8 Hz, 1H), 3.36 (td,
J = 10.8, 2.9 Hz, 2H), 3.76 (s, 1H), 3.98 (dd, J = 15.1, 10.6 Hz, 4H),
4.53 (dd, J = 8.1, 4.4 Hz, 1H), 4.67–4.73 (m, 2H); 13C NMR (CDCl3):
d = 22.16, 26.34, 27.35, 34.68, 37.75, 40.96, 44.66, 45.13, 76.30,
76.46, 76.68, 78.45, 78.54; 11B NMR (CDCl3): d = 10.80; Anal. calcd
for C13H22BNO4: C, 58.45, H, 8.30, N, 5.24; found: C, 58.37, H, 8.42,
N, 5.15.
4.3. General procedure for the synthesis of terpene spiroborate
esters 1–10
To a solution of the corresponding diol (5 mmol) in dry toluene
(10 mL), under a nitrogen atmosphere, was added triisopropyl
borate (1.17 mL, 5.1 mmol) via syringe and the mixture stirred
under mild reflux conditions for approximately 20 min. When
the mixture became homogeneous, a solution of amino alcohol in
dry toluene (10 mL) was added. The mixture was refluxed for
20 min and during this time a portion of toluene along with evolv-
ing isopropanol was removed by distillation (about 10 mL). Next,
toluene (10 mL) was added to the distillation flask and the contents
evaporated again to make sure all the isopropanol had been
removed. After stirring for 20 min, the mixture was cooled to room
temperature and a white precipitate of the spiroborate ester
appeared. The product was filtered and recrystallized from toluene
as a white crystalline powder.
4.3.5. (1R,2S,3R,5R)-2-(10,30,20-Dioxaborolan-(40-1,50-2-cyclopen-
tan)-20-yloxy)-apopinan-3-amine 5
White solid; mp 197–200 °C; [
a]
20 = ꢀ17.0 (c 0.5, THF); 1H NMR
D
(CDCl3): d = 0.98 (d, J = 10.6 Hz, 1H), 1.06 (s, 3H), 1.20 (s, 3H), 1.44–
1.57 (m, 3H), 1.67–1.83 (m, 4H), 1.94 (q, J = 5.2 Hz, 1H), 2.22–2.26
(m, 1H), 2.34–2.38 (m, 1H), 2.54 (ddd, J = 14.1, 10.5, 4.7 Hz, 1H),
3.69 (q, J = 7.9 Hz, 1H), 4.44 (dd, J = 8.3, 4.5 Hz, 1H), 4.48 (br s, 2H),
4.51 (dd, J = 3.5, 1.6 Hz, 2H); 13C NMR (CDCl3): d 22.16, 22.64,
26.20, 27.34, 34.29, 35.12, 35.20, 37.84, 40.96, 44.76, 45.29, 76.78,
79.24, 79.31; 11B NMR (CDCl3): d = 11.04; Anal. calcd for C14H24
-
BNO3: C, 63.42, H, 9.12, N, 5.28; found: C, 63.27, H, 9.41, N, 5.41.
4.3.6. (1S,3S,4R,6R)-3-(10,30,20-Dioxaborolan-20-yloxy)-caran-4-
4.3.1. (1R,2S,3R,5R)-2-(10,30,20-Dioxaborolan-20-yloxy)-apopinan-
3-amine 1
amine 6
White solid; mp 164–166 °C; [a]
20 = +33.3 (c 0.6, THF); 1H NMR
D
White solid; mp 110–113 °C; [
a
]
20 = ꢀ23.8 (c 0.5, THF); 1H NMR
(CDCl3): d = 1.24 (s, 3H), 1.29 (s, 3H), 1.35 (s, 3H), 1.37 (d, J = 8.0,
1H), 2.05 (t, J = 5.4 Hz, 1H), 2.14–2.34 (m, 3H), 3.17 (s, 3H), 3.87
(s, 4H), 4.25 (d, J = 8.8 Hz, 1H), 4.43 (br s, 2H); 13C NMR (CDCl3):
d = 19.18, 22.98, 25.94, 28.87, 37.32, 44.16, 48.85, 51.47, 56.37,
64.27 (2 ꢁ C), 73.98, 80.90; 11B NMR (CDCl3): d = 10.40; Anal. calcd
for C13H24BNO4: C, 58.01, H, 8.99, N, 5.20; found: C, 58.14, H, 9.07,
N, 5.27.
D
(CDCl3): d = 0.95 (d, J = 10.6 Hz, 1H), 1.04 (s, 3H), 1.18 (s, 3H), 1.72
(dd, J = 13.3, 5.8 Hz, 1H), 1.93 (q, J = 5.2 Hz, 1H), 2.21–2.24 (m, 1H),
2.31–2.33 (m, 1H), 2.51–2.54 (m, 1H), 3.64–3.71 (m, 1H), 3.83 (s,
4H), 4.40–4.47 (m, 1H), 4.92 (br s, 2H); 13C NMR (CDCl3): d = 22.20,
26.32, 27.48, 34.16, 38.04, 40.98, 44.84, 45.82, 64.22 (2 ꢁ C),
77.16; 11B NMR (CDCl3): d = 10.24; Anal. calcd for C11H20BNO3: C,
58.69; H, 8.96; N, 6.22; found: C, 58.24; H, 8.67; N, 6.59.
4.3.7. (1S,2S,3S,4S,5R)-3-(10,30,20-Dioxaborolan-20-yloxy)-2-methoxy-
4.3.2. (1R,2S,3R,5R)-2-(10,30,20-Dioxaborolan-(40-2,50-3-(1R,2R,3S,
5R)-pinan)-20-yloxy)-apopinan-3-amine 2
pinan-4-amine 7
White solid; mp 123–124 °C; [
a
]
D
20 = ꢀ26.4 (c 0.5, THF); 1H NMR
White solid; mp 146–148 °C; [
a
]
20 = ꢀ20.6 (c 0.6, THF); 1H NMR
(CDCl3): d = 0.85 (s, 3H), 1.29 (d, J = 10.4 Hz, 1H), 1.31 (s, 3H), 1.42
(s, 3H), 1.86–1.98 (m, 2H), 2.06 (t, J = 5.2 Hz, 1H), 2.23–2.31 (m,
1H), 2.36 (ddt, J = 14.8, 8.4, 2.0 Hz, 1H), 3.66 (t, J = 7.6 Hz, 2H),
4.28–4.39 (m, 1H), 4.49 (t, J = 7.6 Hz, 2H), 6.89 (br s, 2H); 13C
NMR (CDCl3): d = 23.98, 26.34, 27.08, 28.53, 35.70, 38.40, 39.46,
51.55, 66.98, 73.74, 77.21, 84.78; 11B NMR (CDCl3): d = 11.04; Anal.
calcd for C12H22BNO3: C, 60.27, H, 9.27, N, 5.86; found: C, 60.25, H,
9.33, N, 5.76.
D
(CDCl3): d = 0.84 (s, 3H), 1.05 (d, J = 10.8 Hz, 1H), 1.07 (s, 3H), 1.22
(s, 3H), 1.26 (s, 3H), 1.33 (s, 3H), 1.46 (d, J = 10.4 Hz, 1H), 1.72 (dd,
J = 13.7, 6.5 Hz, 1H), 1.81–1.90 (m, 2H), 1.91–2.04 (m, 2H), 2.09–
2.28 (m, 2H), 2.28–2.45 (m, 2H), 2.45–2.57 (m, 1H), 3.38 (br s,
2H), 3.70 (q, J = 8.1 Hz, 1H), 4.12 (dd, J = 8.6, 1.7 Hz, 1H), 4.52 (dd,
J = 8.5, 4.5 Hz, 1H); 13C NMR (CDCl3): d = 22.48, 24.19, 26.09,
27.07, 27.36 (2 ꢁ C), 29.69, 34.76, 37.15, 37.99, 38.18, 40.03,
´
´